AI Image
Popular blood pressure drug recalled over dissolution issues
New York Post • • business
Key Points:
- Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of Chlorthalidone Tablets, USP, 25 mg due to failure in dissolution testing, which affects the medication's effectiveness in treating high blood pressure.
- This is the second recall of chlorthalidone by Inventia Healthcare this year, with the FDA classifying both recalls as Class II, indicating a low risk of serious adverse health consequences.
- Chlorthalidone is a diuretic used to lower blood pressure by increasing urine output, and reduced drug efficacy could raise the risk of stroke, heart attack, and kidney damage if blood pressure is not properly managed.
- Patients taking the recalled medication are advised to consult their healthcare provider before stopping use, as abrupt discontinuation may lead to dangerous health risks including sudden blood pressure increases.
- Consumers can check if their medication is affected by comparing batch numbers RISA24001, RISB24002, and RISA24002, with recall numbers D-0852-2026 and D-0610-2026 listed by the FDA.
